journal article·2017-07

Halloysite and chitosan oligosaccharide nanocomposite for wound healing

Giuseppina Sandri, Carola Aguzzi, Silvia Rossi, Maria Cristina Bonferoni, Giovanna Bruni, Cinzia Boselli, Antonia Icaro Cornaglia, Federica Riva, Cesar Viseras, Carla Caramella, Franca Ferrari

Acta Biomaterialia· Volume 57
Publisher page

Abstract

Halloysite is a natural nanotubular clay mineral (HNTs, Halloysite Nano Tubes) chemically identical to kaolinite and, due to its good biocompatibility, is an attractive nanomaterial for a vast range of biological applications. Chitosan oligosaccharides are homo- or heterooligomers of N-acetylglucosamine and D-glucosamine, that accelerate wound healing by enhancing the functions of inflammatory and repairing cells. The aim of the work was the development of a nanocomposite based on HNTs and chitosan oligosaccharides, to be used as pour powder to enhance healing in the treatment of chronic wounds. A 1:0.05 wt ratio HTNs/chitosan oligosaccharide nanocomposite was obtained by simply stirring the HTNs powder in a 1% w/w aqueous chitosan oligosaccharide solution and was formed by spontaneous ionic interaction resulting in 98.6% w/w HTNs and 1.4% w/w chitosan oligosaccharide composition. Advanced electron microscopy techniques were considered to confirm the structure of the hybrid nanotubes. Both HTNs and HTNs/chitosan oligosaccharide nanocomposite showed good in vitro biocompatibility with normal human dermal fibroblasts up to 300μg/ml concentration and enhanced in vitro fibroblast motility, promoting both proliferation and migration. The HTNs/chitosan oligosaccharide nanocomposite and the two components separately were tested for healing capacity in a murine (rat) model. HTNs/chitosan oligosaccharide allowed better skin reepithelization and reorganization than HNTs or chitosan oligosaccharide separately. The results suggest to develop the nanocomposite as a medical device for wound healing. Statement of significance The present work is focused on the development of halloysite and chitosan oligosaccharide nanocomposite for wound healing. It considers a therapeutic option for difficult to heal skin lesions and burns. The significance of the research considers two fundamental aspects: the first one is related to the development of a self-assembled nanocomposite, formed by spontaneous ionic interaction, while the second one is related to the possibility to find an effective treatment for cutaneous non healing lesions. The characterization of this hybrid system involves a multidisciplinary approach considering integrated techniques of solid state investigation and advanced electron microscopies, and in vitro/in vivo models to understand biocompatibility and proliferation properties (enhancement of in vitro fibroblast motility, proliferation and migration, and of in vivo burn healing), to understand safety and effectiveness of the developed nanocomposite.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (26)

Show source-provided references
1. Biomaterials and nanotherapeutics for enhancing skin wound healing10.3389/fbioe.2016.00082 ↗
2. The wound healing process: an overview of the cellular and molecular mechanisms10.1177/147323000903700531 ↗
3. Cutaneous wound healing10.1056/NEJM199909023411006 ↗
4. Modelling of cell-tissue interactions in skin
5. Introduction to biomaterials for wound healing
6. Clay: new opportunities for tissue regeneration and biomaterial design
7. Clay minerals for tissue regeneration, repair and engineering
8. Evaluation of toxicity of nanoclays and graphene oxide in vivo: a Paramecium caudatum study10.1039/C5EN00201J ↗
9. The origin of spheroidal halloysites: a review of the literature10.1180/claymin.2016.051.3.13 ↗
10. Clay nanotube-biopolymer composite scaffolds for tissue engineering10.1039/C6NR00641H ↗
11. Halloysite clay nanotubes for tissue engineering10.2217/nnm-2016-0250 ↗
12. Halloysite clay nanotubes as a ceramic “skeleton” for functional biopolymer composites with sustained drug release10.1039/c3tb20059k ↗
13. Functional polymer-clay nanotube composites with sustained release of chemical agent10.1016/j.progpolymsci.2013.05.009 ↗
14. Halloysite clay nanotubes for loading and sustained release of functional compounds10.1002/adma.201502341 ↗
15. Enzyme-activated intracellular drug delivary with tubule clay nanoformulation10.1038/srep10560 ↗
16. Application of halloysite clay nanotubes as a pharmaceutical excipient10.1016/j.ijpharm.2017.02.055 ↗
17. New approach to characterization of hydrid nanocomposites10.1016/j.colsurfa.2016.08.079 ↗
18. The application of halloysite tubule nanoclay in drug delivery10.1517/17425247.2016.1169271 ↗
19. Chitosan oligosaccharide: biological activities and potential therapeutic applications10.1016/j.pharmthera.2016.10.013 ↗
20. Chitooligosaccharide and its derivatives: preparation and biological applications10.1155/2014/654913 ↗
21. Release kinetics of 5-aminosalicylic acid from halloysite10.1016/j.colsurfb.2012.12.041 ↗
22. Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing10.1016/j.colsurfb.2013.08.043 ↗
23. Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties10.1016/j.carbpol.2013.10.029 ↗
24. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms10.1016/j.ijpharm.2003.11.023 ↗
25. Characterisation of halloysite for use as a microtubular drug delivery system10.1016/S0378-5173(02)00274-0 ↗
26. Chitosan/halloysite nanotubes bionanocomposites: structure, mechanical properties and biocompatibility10.1016/j.ijbiomac.2012.06.022 ↗